BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 16890027)

  • 1. Impact of surveillance on survival of patients with initial hepatocellular carcinoma: a study from Japan.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1170-6. PubMed ID: 16890027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surveillance program for early detection of hepatocellular carcinoma in Japan: results of specialized department of liver disease.
    Ando E; Kuromatsu R; Tanaka M; Takada A; Fukushima N; Sumie S; Nagaoka S; Akiyoshi J; Inoue K; Torimura T; Kumashiro R; Ueno T; Sata M
    J Clin Gastroenterol; 2006; 40(10):942-8. PubMed ID: 17063116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the characteristics and survival rate of hepatocellular carcinoma from 1976 to 2000: analysis of 1365 patients in a single institution in Japan.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kitabatake S; Kuzuya T; Nonogaki K; Kasugai T; Shimizu J
    Cancer; 2004 Jun; 100(11):2415-21. PubMed ID: 15160346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
    J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal treatment strategy for elderly patients with hepatocellular carcinoma.
    Dohmen K; Shirahama M; Shigematsu H; Irie K; Ishibashi H
    J Gastroenterol Hepatol; 2004 Aug; 19(8):859-65. PubMed ID: 15242487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of newer treatment modalities on survival in patients with hepatocellular carcinoma.
    Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Fujimoto M; Kusumoto K; Motoyoshi Y; Shibata H; Eguchi K
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1177-83. PubMed ID: 16901768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study.
    Yamagiwa K; Shiraki K; Yamakado K; Mizuno S; Hori T; Yagi S; Hamada T; Iida T; Nakamura I; Fujii K; Usui M; Isaji S; Ito K; Tagawa S; Takeda K; Yokoi H; Noguchi T
    J Gastroenterol Hepatol; 2008 Mar; 23(3):482-90. PubMed ID: 18086115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does surveillance for hepatocellular carcinoma in HCV cirrhotic patients improve treatment outcome mainly due to better clinical status at diagnosis?
    Giannini E; Arzani L; Borro P; Botta F; Fasoli A; Risso D; Celle G; Testa R
    Hepatogastroenterology; 2000; 47(35):1395-8. PubMed ID: 11100360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical benefits of hepatocellular carcinoma surveillance: a single-center, hospital-based study.
    Taura N; Hamasaki K; Nakao K; Ichikawa T; Nishimura D; Goto T; Fukuta M; Kawashimo H; Motoyoshi Y; Shibata H; Eguchi K
    Oncol Rep; 2005 Oct; 14(4):999-1003. PubMed ID: 16142364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in clinical characteristics, treatment and prognosis of hepatocellular carcinoma.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):1872-7. PubMed ID: 14696422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Early diagnosis and improved survival with screening for hepatocellular carcinoma].
    Youk CM; Choi MS; Paik SW; Ahn BH; Lee JH; Koh KC; Yoo BC; Rhee JC
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):116-23. PubMed ID: 12824751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do young hepatocellular carcinoma patients with relatively good liver function have poorer outcomes than elderly patients?
    Cho SJ; Yoon JH; Hwang SS; Lee HS
    J Gastroenterol Hepatol; 2007 Aug; 22(8):1226-31. PubMed ID: 17498220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing paradigm in the management of hepatocellular carcinoma improves the survival benefit of early detection by screening.
    Chan AC; Poon RT; Ng KK; Lo CM; Fan ST; Wong J
    Ann Surg; 2008 Apr; 247(4):666-73. PubMed ID: 18362630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and prognosis of patients with hepatocellular carcinoma after the year 2000 in Japan.
    Toyoda H; Kumada T; Tada T; Sone Y; Kaneoka Y; Maeda A
    J Gastroenterol Hepatol; 2011 Dec; 26(12):1765-71. PubMed ID: 21615793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival in hepatocellular carcinoma: impact of screening and etiology of liver disease.
    Kemp W; Pianko S; Nguyen S; Bailey MJ; Roberts SK
    J Gastroenterol Hepatol; 2005 Jun; 20(6):873-81. PubMed ID: 15946134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors that affect risk for hepatocellular carcinoma and effects of surveillance.
    Yang JD; Harmsen WS; Slettedahl SW; Chaiteerakij R; Enders FT; Therneau TM; Orsini L; Kim WR; Roberts LR
    Clin Gastroenterol Hepatol; 2011 Jul; 9(7):617-23.e1. PubMed ID: 21459158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term trends and geographic variations in the survival of patients with hepatocellular carcinoma: analysis of 11,312 patients in Taiwan.
    Chen CH; Su WW; Yang SS; Chang TT; Cheng KS; Lin HH; Wu SS; Lee CM; Changchien CS; Chen CJ; Sheu JC; Chen DS; Lu SN
    J Gastroenterol Hepatol; 2006 Oct; 21(10):1561-6. PubMed ID: 16928217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance.
    Trevisani F; Magini G; Santi V; Morselli-Labate AM; Cantarini MC; Di Nolfo MA; Del Poggio P; Benvegnù L; Rapaccini G; Farinati F; Zoli M; Borzio F; Giannini EG; Caturelli E; Bernardi M;
    Am J Gastroenterol; 2007 May; 102(5):1022-31. PubMed ID: 17313497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma in the Netherlands incidence, treatment and survival patterns.
    Verhoef C; Visser O; de Man RA; de Wilt JH; IJzermans JN; Janssen-Heijnen ML
    Eur J Cancer; 2004 Jul; 40(10):1530-8. PubMed ID: 15196537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.